Micafungin (Mycamine®) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (MICADO).
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Micafungin (Primary)
- Indications Aspergillosis; Candidaemia; Candidiasis
- Focus Pharmacokinetics
- Acronyms MICADO
- 24 Apr 2018 Results assessing pharmacokinetics of micafungin in obese and normal-weight subjects were presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 26 Sep 2017 Status changed from recruiting to completed.
- 07 Apr 2017 New trial record